Paul Tudor Jones Sangamo Therapeutics, Inc Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 363,490 shares of SGMO stock, worth $897,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares

363,490

Previous 363,490 -0.0%

Holding current value

$897,820

Previous $130,000 140.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $19,335 - $42,748	-11,648 Reduced 3.1%	363,490 $640,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $952,553 - $1.74 Million	343,882 Added 1100.21%	375,138 $1.18 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $482,761 - $722,447	-113,059 Reduced 78.34%	31,256 $153,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $327,134 - $619,360	99,736 Added 223.73%	144,315 $597,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $613,280 - $916,988	-117,262 Reduced 72.46%	44,579 $259,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $587,275 - $883,732	80,559 Added 99.11%	161,841 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $732,350 - $976,196	81,282 New	81,282 $732,000
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $873,776 - $1.72 Million	-94,667 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $254,141 - $338,133	27,094 Added 40.1%	94,667 $895,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $419,628 - $799,388	67,573 New	67,573 $605,000
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $114,402 - $189,831	-14,819 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $140,928 - $245,995	14,819 New	14,819 $170,000
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $916,228 - $1.45 Million	-54,864 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $276,718 - $413,884	23,855 Added 76.93%	54,864 $900,000
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $260,475 - $465,135	31,009	31,009 $465,000

Others Institutions Holding SGMO

# of Institutions

115

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $387M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account